⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

October 25, 2005Circulation

Type 5 Phosphodiesterase Inhibition

View Full Paper

Ask AI

Bookmark

Share

Authors

MSMarc J. SemigranHeart Failure & Transplant

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Marc J. Semigran (2005) studied this question.

synapsesocial.com/papers/6a767595d3a6aa87c6bd33bb https://doi.org/10.1161/circulationaha.105.577627

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1Cardiac phosphodiesterase 5 (cGMP‐specific) modulates β‐adrenergic signaling in vivo and is down‐regulated in heart failure2001 · 230 citations
2Ca2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes.1991 · 476 citations
3Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility1999 · 202 citations
4Pertussis toxin-sensitive G proteins influence nitric oxide synthase III activity and protein levels in rat heart.1998 · 58 citations